Global Zygomatic and Pterygoid Implants Market is Segmented By Product Length (Upto 30 mm, 30 - 50 mm, Above 50 mm), By Application (Severe Atrophy of Maxillary Bone, Maxillary Sinuses, Other Applications), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Overview
The Zygomatic and Pterygoid Implants Market is expected to grow at a CAGR of 6.1% during the forecast period 2024-2031
Zygomatic and pterygoid implants are specialized dental implants used to support prosthetic teeth in patients with severe bone loss in the upper jaw. The market is driven by the increasing demand for dental implant solutions, technological advancements in implant design, and the rising prevalence of edentulism. In Europe, the Zygomatic and Pterygoid Implants Market is experiencing substantial growth. Key players in the market include Straumann Holding AG, Nobel Biocare Services AG, Zimmer Biomet Holdings, Inc., and other prominent players.
Market Summary
| Metrics | Details |
| Market CAGR | 6.1% |
| Segments Covered | By Product Length, By Application, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | Europe |
For more insights - Download the Sample
Market Dynamics
Zygomatic and pterygoid implants market growth is driven by the growing geriatric population contributing to the increasing incidences of dental ailments and injuries and proven advantageous procedures with implants as compared to conventional substitutes.
Growing adoption of zygomatic and pterygoid implants is expected to hold the largest share in this market segment
According to an October 2020 update by the World Health Organization (WHO), by 2030, 1 of every 6 individuals will be mature 60 years or above. As the maturing populace is inclined to experience dental sicknesses like maxillary resorption and expanded bone misfortune, the interest in zygomatic and pterygoid inserts are supposed to develop with the developing geriatric populace. What's more, demonstrated profitable techniques with these inserts are a central point driving the interest in zygomatic and pterygoid inserts. For example, according to an April 2021 distributed article named, "Tubero Pterygoid Implants-A Boom for Atrophied Maxillary Ridges: Systematic Review and Meta-Analysis," it was presumed that tubero-pterygoid inserts could be effectively utilized in patients with an atrophic back maxilla.
In addition, as indicated by the February 2019 distributed article named "Pterygoid embed, Option for restoration of the atrophic back maxilla," pterygoid inserts stay away from the requirement for sinus lifts and uniting strategies and permit dock in the back decayed or resorbed maxilla, accomplishing appropriate dependability, and high paces of long-haul achievement. Consequently, these examinations showing the benefits of utilizing pterygoid inserts mirror the developing reception of such embeds among the patient population.
The growing rate of complications linked to implant-associated infections is expected to hamper the market growth
Implant-related contaminations (IAIs) are a feared entanglement brought about by biofilm-framing staphylococci. The main issue emerging from the presence of an embed in people is the unfavorably susceptible/easily affected response and incendiary reaction that might be mounted by the host's invulnerable framework against the embed/gadget. Since an embed stays for an extensive stretch going from a couple of months to quite a long while, the event of IAIs and their capability to cause extreme dismalness is much of the time a reason for genuine concern.
PEST Analysis:
COVID-19 Impact on Market
The COVID-19 episode was an uncommon well-being concern and had fundamentally affected the zygomatic inserts and pterygoid inserts market. In the first and second quarters of 2020, the flare of the COVID-19 pandemic firmly affected the zygomatic and pterygoid inserts market as emergency clinic and dental center activities were essentially decreased because of lockdown and social separating measures attempted by legislatures across the world. In March 2020, the American Dental Association (ADA), the country's biggest dental affiliation, suggested that dental specialists defer elective dental systems until April 6, 2020, and give crisis just dental administrations to assist with holding patients back from troubling clinic crisis divisions. This suggestion was refreshed on April 1, 2020, when the ADA encouraged workplaces to stay shut to everything except dire and crisis techniques until April 30, at the earliest, inferable from the rising number of COVID-19 cases. Hence, this significantly impacted dental administrations, along these lines diminishing the interest in zygomatic and pterygoid inserts.
Market Segment Analysis
The independent controls segment is expected to hold the largest share in this market segment
Severe atrophy of the maxillary bone fragment is supposed to hold a significant portion of the overall industry. Bone atrophy likewise alluded to as osteonecrosis of the jaw happens when the basic jawbone starts to break down. The elements adding to the portion's development are the rising frequencies of serious decay of the maxillary bone, the developing geriatric population, and the execution of strategic initiatives by the market players.
According to a January 2021 distributed article named "Zygomatic inserts put in the atrophic maxilla: an outline of current methodical audits and meta-investigation," zygomatic inserts seem to offer a promising option in contrast to formal bone uniting strategies with lower costs, fewer complexities, less dismalness, more limited treatment times, and similarly high endurance rates, such examinations mirror the developing interest for zygomatic inserts for serious decay of the maxilla, consequently adding to the fragment's development.
Consequently, the section is supposed to develop fundamentally over the forecast period because of the variables referenced previously.
Market Geographical Share
Europe region holds the largest market share of the global zygomatic and pterygoid implants market
The Europe region is anticipated to hold a major market share in the global zygomatic and pterygoid implants market due to the increasing geriatric population leading to a rise in incidence rates of dental ailments and injuries. For instance, as per a 2022 update by Eurostat Statistics, the share of people aged 80 years or above in the European region's population is projected to have a two-and-a-half-fold increase between 2021 and 2100, from 6.0% to 14.6%. Likewise, according to the European Federation of Periodontology, in Europe, periodontal diseases are the most common conditions. Eight out of ten individuals over 35 years of age suffer from gum diseases. Moreover, periodontal diseases represent a major cause of expenditure in the adult and geriatric population.
Moreover, an increasing number of orthodontic procedures contributes to market growth. For example, as per the 2019 British Orthodontic Society survey, the number of adults seeking orthodontic treatment in the United Kingdom remains high. Therefore, this indicates the high demand for zygomatic and pterygoid implants in the region, thereby contributing to the market's growth.
Companies and Competitive Landscape
The global zygomatic and pterygoid implants market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Straumann Holding AG, Noris Medical, S.I.N. Implant System, Southern Implants, IDC Implant & Dental Company, Danaher Corporation (Nobel Biocare), Titaniumfix, Implance, Bioline Dental Implants, and Osseosource. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the zygomatic and pterygoid implants globally. For instance, In December 2020, Nuffield Dental Group, a premium dental clinic in Singapore, launched its 10th state-of-the-art dental technology clinic in Singapore. Zygomatic implants at Nuffield are an alternative solution for weak bone density complications in a patient's upper jaw.
Global Zygomatic and Pterygoid Implants Market – Key Companies to Watch
Straumann Holding AG
Overview: Headquartered in Basel, Switzerland, the Straumann Group researches and develops, manufactures, and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic, and preventative dentistry.
Product Portfolio: It includes products like Straumann Zygomatic Implant System- ZAGA Round and ZAGA Flat.
